Y-6 Sublingual Tablets for Acute Ischemic Stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an investigational sublingual tablet called Y-6 for people having an acute ischemic stroke (a stroke caused by a clot). It may help improve recovery when given within 24 hours of stroke onset, alongside standard endovascular treatment to remove the clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 80 years old.
- You had a stroke caused by a clot in a large brain artery, confirmed by imaging, and can get endovascular treatment within 24 hours of symptoms starting.
- This is your first stroke, or you had no significant disability before it (mRS score 0-1).
- Your stroke severity score (NIHSS) is between 6 and 25 at the time of screening.
- Your brain scan shows an ASPECTS score of 6 or higher (meaning limited damage).
- You or your legal representative can understand and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This trial studies an herbal treatment given after an ischemic stroke to see if it improves recovery during rehab. It may help people regain more movement and daily function after stroke.
This study tests a new tablet (Y-6), placed under the tongue, for treating a small, deep stroke. It aims to help people recover better if given within 72 hours of symptoms starting and without severe artery blockages or bleeding risks.
This trial tests whether XY03-EA tablets can help people recover after an acute ischemic stroke. Participants must have had a stroke within the last 48 hours and have moderate to severe symptoms but not be in a coma.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.